Literature DB >> 30888973

The interaction of gender and smoking on bladder cancer risks.

Florian Janisch1,2, Shahrokh F Shariat1,3,4,5,6,7, Eva Schernhammer8,9,10, Michael Rink2, Harun Fajkovic1,5.   

Abstract

PURPOSE OF REVIEW: Although smoking and gender are well-established bladder cancer (BCa) risk factors, a significant interaction with other risk factors could help in the identification of patterns for early detection and prevention strategies. RECENT
FINDINGS: Smoking appears to be more strongly associated with BCa risk in women than in men, which could be related to differences in metabolism, smoking behavior, exposure patterns, and DNA repair mechanisms. BMI is associated with a higher risk of BCa with negligible difference between genders. The risk for BCa is increased in postmenopausal women, specifically in women with earlier menopausal age (<45 years). Other potential risk factors such as alcohol, arsenic exposure, and particulate matter inhalation seem to affect the genders differently.Female smokers experience a higher risk of disease recurrence after bacillus Calmette-Guérin therapy than their male counterparts. Lastly, smoking appears to negatively affect the outcome of radiotherapy in women, but not that of men.
SUMMARY: Several lines of evidence point to an interaction between smoking and gender, whereas their impact on other potential risk factors remains to be elucidated. Identifying such differential effects could allow for gender-specific prevention, early detection, and treatment strategies.

Entities:  

Mesh:

Substances:

Year:  2019        PMID: 30888973     DOI: 10.1097/MOU.0000000000000602

Source DB:  PubMed          Journal:  Curr Opin Urol        ISSN: 0963-0643            Impact factor:   2.309


  11 in total

Review 1.  [Gender-associated differences in bladder cancer].

Authors:  Georgios Gakis; Dorothea Weckermann
Journal:  Urologie       Date:  2022-08-18

2.  A simplified nomogram to assess risk of bladder cancer in patients with a new diagnosis of microscopic hematuria.

Authors:  Richard S Matulewicz; Alfred Rademaker; Joshua J Meeks
Journal:  Urol Oncol       Date:  2020-01-14       Impact factor: 3.498

3.  Genetic Variants of lncRNA GAS5 Are Associated with the Clinicopathologic Development of Oral Cancer.

Authors:  Ming-Hong Hsieh; Hsueh-Ju Lu; Chiao-Wen Lin; Chia-Yi Lee; Shang-Jung Yang; Pei-Hsuan Wu; Mu-Kuan Chen; Shun-Fa Yang
Journal:  J Pers Med       Date:  2021-04-26

4.  Education and Lifestyle Factors Are Associated with DNA Methylation Clocks in Older African Americans.

Authors:  Wei Zhao; Farah Ammous; Scott Ratliff; Jiaxuan Liu; Miao Yu; Thomas H Mosley; Sharon L R Kardia; Jennifer A Smith
Journal:  Int J Environ Res Public Health       Date:  2019-08-28       Impact factor: 3.390

5.  Gender differences in trends of bladder cancer mortality-to-incidence ratios according to health expenditure in 55 countries.

Authors:  Cheng-Yu Huang; Shao-Chuan Wang; Lung Chan; Tzuo-Yi Hsieh; Wen-Wei Sung; Sung-Lang Chen
Journal:  PLoS One       Date:  2021-02-12       Impact factor: 3.240

6.  Smoking status and pathological response to neoadjuvant chemotherapy among patients with bladder cancer: a pooled analysis.

Authors:  Tongchen He; Jiao Hu; Dongxu Qiu; Hao Deng; Jian Hu; Jinbo Chen; Xiongbing Zu
Journal:  Transl Androl Urol       Date:  2021-01

7.  Urinary Angiogenin as a Marker for Bladder Cancer: A Meta-Analysis.

Authors:  Amir Hossein Aalami; Hossein Abdeahad; Mohammad Mesgari; Thozhukat Sathyapalan; Amirhossein Sahebkar
Journal:  Biomed Res Int       Date:  2021-04-27       Impact factor: 3.411

8.  The Prognostic Significance of Proteasome 26S Subunit, Non-ATPase (PSMD) Genes for Bladder Urothelial Carcinoma Patients.

Authors:  AbdulFattah Salah Fararjeh; Ali Al-Khader; Malak Al-Saleem; Rinad Abu Qauod
Journal:  Cancer Inform       Date:  2021-12-22

Review 9.  Quality indicators for the management of muscle-invasive bladder cancer in the perioperative setting of radical cystectomy: a narrative review.

Authors:  Frederik König; Benjamin Pradere; Nico C Grossmann; Fahad Quhal; Pawel Rajwa; Ekaterina Laukhtina; Keiichiro Mori; Satoshi Katayama; Takafumi Yanagisawa; Hadi Mostafai; Reza Sari Motlagh; Abdulmajeed Aydh; Roland Dahlem; Shahrokh F Shariat; Michael Rink
Journal:  Transl Cancer Res       Date:  2022-04       Impact factor: 1.241

10.  Androgen Receptor Regulates CD44 Expression in Bladder Cancer.

Authors:  Joseph L Sottnik; Lauren Vanderlinden; Molishree Joshi; Ana Chauca-Diaz; Charles Owens; Donna E Hansel; Colin Sempeck; Debashis Ghosh; Dan Theodorescu
Journal:  Cancer Res       Date:  2021-03-09       Impact factor: 13.312

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.